In the mild cognitive impairment (MCI) stage, as the disease progresses, the dysregulation of the PI3K/Akt signaling axis and the consequent hyperactivity of GSK3β contribute to the formation of toxic tau species and the accumulation of Aβ. The gene discussed is MAPT; the disease is Cognitive impairment.